Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Certain hormone treatments can improve acne and related conditions in women.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

More body hair in young Australian women is linked to higher androstenedione levels.

New treatments for PCOS focus on managing symptoms and improving fertility.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

The free androgen index varies among women with different types of PCOS.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.